34 In a similarly sized double-blind, placebo-controlled study of intravenous ketamine (0.2 mg/kg) for treatment of migraine in the emergency department setting, however, ketamine was not superior to placebo for acute pain relief and caused adverse effects of generalized discomfort at 30 minutes and fatigue at 60 minutes, although no serious adverse events occurred
* Such #comprehensive #care will support #treatment #benefits beyond body weight alone and will make clinicians more effective stewards of GLP-1s and, ultimately, of patients' overall #health
10.1016/j.arcped.2019.02.011 49
Medically reviewed by Lauren Okafor | MD , The Frank H Netter MD School of Medicine, Loyola University Medical Center on March 16th, 2026
David became CEO in January 2017 and was elected chair of the companys board of directors effective June 2017
This combination is ideal for individuals struggling with obesity, insulin resistance, or weight-related metabolic conditions , and is delivered through once-weekly subcutaneous injections under the guidance of a licensed provider